Severe gastroenteritis as presentation of a primary cytomegalovirus infection in an immunocompetent woman

por Schreuder, Ramon-Michel, de Groot, Jan-Willem, Kamper, Adriaan M.
Publicado 2011

An Introduction to Managing Medullary Thyroid Cancer

por de Groot, Jan Willem, Links, Thera P, Hofstra, Robert MW, Plukker, John TM
Publicado 2006

Tolerability of Capecitabine Monotherapy in Metastatic Colorectal Cancer: A Real-World Study

por Leicher, Laura W., de Graaf, Jacques C., Coers, Wilko, Tascilar, Metin, de Groot, Jan Willem B.
Publicado 2016

Lactate dehydrogenase: a marker of diminished antitumor immunity

por Van Wilpe, Sandra, Koornstra, Rutger, Den Brok, Martijn, De Groot, Jan Willem, Blank, Christian, De Vries, Jolanda, Gerritsen, Winald, Mehra, Niven
Publicado 2020

Role of Patient-Reported Outcomes in Clinical Trials in Metastatic Colorectal Cancer: A Scoping Review

por Maring, Jan Gerard, Eijsink, Job F. H., Tichelaar, Friso D., Veluwenkamp-Worawutputtapong, Pawida, Postma, Maarten J., Touw, Daan J., de Groot, Jan Willem B.
Publicado 2023

Possible Value of Faecal Immunochemical Test (FIT) When Added in Symptomatic Patients Referred for Colonoscopy: A Systematic Review

por Brands, Henrike Jacoba, Van Dijk, Brigit, Brohet, Richard M., van Westreenen, Henderik L., de Groot, Jan Willem B., Moons, Leon M. G., de Vos tot Nederveen Cappel, Wouter H.
Publicado 2023

Delayed Surgery after Neoadjuvant Treatment for Rectal Cancer Does Not Lead to Impaired Quality of Life, Worry for Cancer, or Regret

por Meyer, Vincent Maurice, Meuzelaar, Richtje R, Schoenaker, Yvonne, de Groot, Jan-Willem, de Boer, Edwin, Reerink, Onno, de Vos tot Nederveen Cappel, Wouter, Beets, Geerard L, van Westreenen, Henderik L
Publicado 2021

High Yield of Chest X-ray in the Follow-Up of Colorectal Cancer

por Steenhuis, Eline G. M., Schoenaker, Ivonne J. H., De Groot, Jan Willem B., Stigt, Jos A., Reerink, Onne, De Vos tot Nederveen Cappel, Wouter H., Van Westreenen, Henderik L., Brohet, Richard M.
Publicado 2022

Plasma BRAF Mutation Detection for the Diagnostic and Monitoring Trajectory of Patients with LDH-High Stage IV Melanoma

por Tolmeijer, Sofie H., Koornstra, Rutger H. T., de Groot, Jan Willem B., Geerlings, Maartje J., van Rens, Dirk H., Boers-Sonderen, Marye J., Schalken, Jack A., Gerritsen, Winald R., Ligtenberg, Marjolijn J. L., Mehra, Niven
Publicado 2021

Factors Predicting Outcome of Total Thyroidectomy in Young Patients with Multiple Endocrine Neoplasia Type 2: A Nationwide Long-Term Follow-up Study

por Schreinemakers, Jennifer M. J., Vriens, Menno R., Valk, Gerlof D., de Groot, Jan-Willem B., Plukker, John T., Bax, Klaas (N.) M. A., Hamming, Jaap F., van der Luijt, Rob B., Aronson, Daniel C., Borel Rinkes, Inne H. M.
Publicado 2010

Contribution of MEK Inhibition to BRAF/MEK Inhibitor Combination Treatment of BRAF-Mutant Melanoma: Part 2 of the Randomized, Open-Label, Phase III COLUMBUS Trial

por Ascierto, Paolo A., Dummer, Reinhard, Gogas, Helen J., Arance, Ana, Mandala, Mario, Liszkay, Gabriella, Garbe, Claus, Schadendorf, Dirk, Krajsova, Ivana, Gutzmer, Ralf, Chiarion-Sileni, Vanna, Dutriaux, Caroline, de Groot, Jan Willem B., Yamazaki, Naoya, Loquai, Carmen, Robert, Caroline, Flaherty, Keith T.
Publicado 2023

COLUMBUS 5-Year Update: A Randomized, Open-Label, Phase III Trial of Encorafenib Plus Binimetinib Versus Vemurafenib or Encorafenib in Patients With BRAF V600–Mutant Melanoma

por Dummer, Reinhard, Flaherty, Keith T., Robert, Caroline, Arance, Ana, de Groot, Jan Willem B., Garbe, Claus, Gogas, Helen J., Gutzmer, Ralf, Krajsová, Ivana, Liszkay, Gabriella, Loquai, Carmen, Mandalà, Mario, Schadendorf, Dirk, Yamazaki, Naoya, di Pietro, Alessandra, Cantey-Kiser, Jean, Edwards, Michelle, Ascierto, Paolo A.
Publicado 2022

Response and survival of metastatic melanoma patients treated with immune checkpoint inhibition for recurrent disease on adjuvant dendritic cell vaccination

por van Willigen, Wouter W., Bloemendal, Martine, Boers-Sonderen, Marye J., de Groot, Jan Willem B., Koornstra, Rutger H.T., van der Veldt, Astrid A.M., Haanen, John B. A. G., Boudewijns, Steve, Schreibelt, Gerty, Gerritsen, Winald R., de Vries, I. Jolanda M., Bol, Kalijn F.
Publicado 2020

Patients with primary brain tumors and COVID-19: A report from the Dutch Oncology COVID-19 Consortium

por de Joode, Karlijn, Taal, Walter, Snijders, Tom J, Hanse, Monique, Koekkoek, Johan A F, Oomen - de Hoop, Esther, de Groot, Jan Willem B, Kouwenhoven, Mathilde C M, Beerepoot, Laurens V, Dingemans, Anne-Marie C, van den Bent, Martin J, van der Veldt, Astrid A M
Publicado 2021

Early Recurrence in Completely Resected IIIB and IIIC Melanoma Warrants Restaging Prior to Adjuvant Therapy

por Bloemendal, Martine, van Willigen, Wouter W., Bol, Kalijn F., Boers-Sonderen, Marye J., Bonenkamp, Johannes J., Werner, J. E. M., Aarntzen, Erik H. J. G., Koornstra, Rutger H. T., de Groot, Jan Willem B., de Vries, I. Jolanda M., van der Hoeven, Jacobus J. M., Gerritsen, Winald R., de Wilt, Johannes H. W.
Publicado 2019

Safety and Feasibility of Additional Tumor Debulking to First‐Line Palliative Combination Chemotherapy for Patients with Multiorgan Metastatic Colorectal Cancer

por Gootjes, Elske C., van der Stok, Eric P., Buffart, Tineke E., Bakkerus, Lotte, Labots, Mariette, Zonderhuis, Barbara M., Tuynman, Jurriaan B., Meijerink, Martijn R., van de Ven, Peter M., Haasbeek, Cornelis J.A., ten Tije, Albert J., de Groot, Jan‐Willem B., Hendriks, Mathijs P., van Meerten, Esther, Nuyttens, Joost J.M.E., Grunhagen, Dirk J., Verhoef, Cornelis, Verheul, Henk M.W.
Publicado 2020

Circulating TP53 mutations are associated with early tumor progression and poor survival in pancreatic cancer patients treated with FOLFIRINOX

por van der Sijde, Fleur, Azmani, Zakia, Besselink, Marc G., Bonsing, Bert A., de Groot, Jan Willem B., Groot Koerkamp, Bas, Haberkorn, Brigitte C. M., Homs, Marjolein Y. V., van IJcken, Wilfred F. J., Janssen, Quisette P., Lolkema, Martijn P., Luelmo, Saskia A. C., Mekenkamp, Leonie J. M., Mustafa, Dana A. M., van Schaik, Ron H. N., Wilmink, Johanna W., Vietsch, Eveline E., van Eijck, Casper H. J.
Publicado 2021

Serum miR-373-3p and miR-194-5p Are Associated with Early Tumor Progression during FOLFIRINOX Treatment in Pancreatic Cancer Patients: A Prospective Multicenter Study

por van der Sijde, Fleur, Homs, Marjolein Y. V., van Bekkum, Marlies L., van den Bosch, Thierry P. P., Bosscha, Koop, Besselink, Marc G., Bonsing, Bert A., de Groot, Jan Willem B., Karsten, Thomas M., Groot Koerkamp, Bas, Haberkorn, Brigitte C. M., Luelmo, Saskia A. C., Mekenkamp, Leonie J. M., Mustafa, Dana A. M., Wilmink, Johanna W., van Eijck, Casper H. J., Vietsch, Eveline E.
Publicado 2021

Sex, Gender and Age Differences in Treatment Allocation and Survival of Patients With Metastatic Pancreatic Cancer: A Nationwide Study

por Pijnappel, Esther N., Schuurman, Melinda, Wagner, Anna D., de Vos-Geelen, Judith, van der Geest, Lydia G. M., de Groot, Jan-Willem B., Koerkamp, Bas Groot, de Hingh, Ignace H. J. T., Homs, Marjolein Y. V., Creemers, Geert-Jan, Cirkel, Geert A., van Santvoort, Hjalmar C., Busch, Olivier R., Besselink, Marc G., van Eijck, Casper H.J., Wilmink, Johanna W., van Laarhoven, Hanneke W. M.
Publicado 2022

IMPemBra: a phase 2 study comparing pembrolizumab with intermittent/short-term dual MAPK pathway inhibition plus pembrolizumab in patients with melanoma harboring the BRAFV600 muta...

por Rozeman, Elisa A, Versluis, Judith M, Sikorska, Karolina, Hoefsmit, Esmée P, Dimitriadis, Petros, Rao, Disha, Lacroix, Ruben, Grijpink-Ongering, Lindsay G, Lopez-Yurda, Marta, Heeres, Birthe C, van de Wiel, Bart A, Flohil, Claudie, Sari, Aysegul, Heijmink, Stijn W T P J, van den Broek, Daan, Broeks, Annegien, de Groot, Jan Willem B, Vollebergh, Marieke A, Wilgenhof, Sofie, van Thienen, Johannes V, Haanen, John B A G, Blank, Christian U
Publicado 2023